PDCD1LG2 and neoplasm: Use of panHDACi, such as panobinostat, is known to increase the expression of the immunosuppressive proteins such as programmed death ligand-1 (PD-L1) and programmed death ligand-2 (PD-L2) on the cell surface of tumor cells [55].